U.K.-based Peppy raised a $45 million Series B round led by AlbionV to expand in the U.S. market.

Founded in 2018, Peppy offers gender-related health services through employers, including care for menopause, pregnancy, fertility, early parenthood and men's health concerns. The company raised a £6.6 million Series A in 2021. 

In addition to the U.S. expansion, Peppy will use the raise to grow in the U.K., invest in product development, improve its technology, and advance its support services for users and clients.

"This journey is only just beginning in the U.S. The awareness of menopause in the USA is starting to grow, but it can still often be a taboo topic. We’re honored to know that Peppy will be part of a U.S. healthcare movement that brings gender-specific support issues like menopause to the forefront – just as we have done in the UK," Peppy co-CEO and cofounder Mridula Pore wrote in a statement.

Maternity care clinic Oula announced it had raised $19.1 million in Series A funding.

The round was led by 8VC with participation from existing investors including Metrodora, the Female Founders Fund, Collaborative Fund and Alumni Ventures. The Series A brings its total funding to $22.3 million. Oula announced its seed raise in 2020. 

The startup currently has two clinics in New York City. It will use the funding to advance its pregnancy care, expand sonography capabilities and add support groups for parents.

"At Oula, we are focused on providing a great experience and great outcomes for our patients. That means listening to and taking their concerns seriously, prioritizing mental health as well as physical, approaching this work through a lens of equity and inclusivity, hiring diverse and culturally competent staff, providing trauma-informed care, emphasizing the importance of postpartum care and empowering patients to advocate for themselves," Adrianne Nickerson, cofounder and CEO of Oula, said in a statement. 

Male fertility startup Posterity Health scooped up $7.5 million in a round led by Distributed Ventures, with participation from FCA Venture Partners and WVV Capital.

The company offers virtual visits, at-home diagnostics and in-person consultations on male fertility. 

"The expanded Posterity Health network will double the number of reproductive urologists using the platform and provide easy access to in-person care when required," Pam Pure, CEO of Posterity Health, said in a statement.

Healthcare AI company Ferrum Health raised $6 million in a funding round led by Urban Innovation Fund, Cercano Management and Singtel Innov8.

The company raised a $9 million seed in 2020. It plans to use the capital to develop its Enterprise AI Platform, which aims to analyze medical data and provide insights into patient care.